Effect of Estrogen Receptor Status on Circulatory Immune and Metabolomics Profiles of HER2-Positive Breast Cancer Patients Enrolled for Neoadjuvant Targeted Chemotherapy

HER2-positive breast cancer (BC) represents a heterogeneous cancer disease. In an attempt to identify new stratification models useful for prognosis and therapeutic strategy, we investigated the influence of estrogen receptor (ER) status on the host immune and metabolomics profile of HER2-positive B...

Descripción completa

Detalles Bibliográficos
Autores principales: Vignoli, Alessia, Muraro, Elena, Miolo, Gianmaria, Tenori, Leonardo, Turano, Paola, Di Gregorio, Emanuela, Steffan, Agostino, Luchinat, Claudio, Corona, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072610/
https://www.ncbi.nlm.nih.gov/pubmed/32013102
http://dx.doi.org/10.3390/cancers12020314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072610/
https://www.ncbi.nlm.nih.gov/pubmed/32013102
http://dx.doi.org/10.3390/cancers12020314

Ejemplares similares